Blog

Flagship spinout Axcella collapses, leaving future of its long Covid drug uncertain

axcella-2017-corporate-headshots-lab-shots-0027900xx4000-2667-0-2

A Flagship Pioneering-backed biotech behind one of the only new drugs in development for long Covid is closing its doors.

Read More